Project Grant R01AA031497
Award Date
5/2/25
Completion Date
4/30/30
Dollars Obligated
$478K
Federal Agency
National Institute on Alcohol Abuse and Alcoholism
Federal Grant Program
93.273
Assistance Type
Project Grant
Place of Performance
Louisiana, USA
Similar Awards
This $517,379 federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, supports research to investigate the role of KDM5 demethylases in alcohol-associated liver disease (ALD) development and resolution. The project aims to determine how these epigenetic regulators in hepatocytes mediate cellular crosstalk that promotes ALD progression and fibrosis, as well as define the mechanisms by...
This $238,445 Project Grant award was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program. The award supports research to elucidate the mechanism and significance of translatome (mRNA translation) alteration as a critical pathophysiology of alcoholic fatty liver (AFL) disease. The research aims to determine the molecular mechanism of dysregulated translatome in terminally differentiated human...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $438,375 Project Grant under the Alcohol Research Programs (CFDA 93.273) to Cedars-Sinai Medical Center to establish a human liver-on-a-chip model for studying alcohol-associated liver disease (ALD). The 2-year project, starting September 2023, aims to investigate the roles of liver sinusoidal endothelial cells and acetaldehyde metabolism in regulating ethanol-induced liver damage as well as the contribution of fibrotic...
This $374,598 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, supports research to investigate the impact of alcohol consumption on RNA modifications and their potential role in the development and progression of alcohol-associated liver disease (ALD). The key objectives of this 2-year project are to: 1) Map the site-specific chemical modifications on different types of RNAs isolated...
This $119,600 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, aims to identify and understand the mechanisms by which aging and alcohol consumption cooperatively contribute to the overall decline in liver function and the subsequent development of alcohol-associated liver disease (ALD). The award recipient, the University of Kansas Medical Center Research Institute, Inc. (KUMCRI),...
This federal Project Grant award, provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), will support research into the mechanisms behind HIV-induced liver fibrosis and the role of alcohol use disorders. The $220,656 award, effective from August 8, 2024 to July 31, 2026, will enable the research team at the University of Nebraska Medical Center to investigate how alcohol metabolism affects the sorting of HIV proteins into...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) provides funding of $386,196 to the University of Kansas Medical Center Research Institute, Inc. to conduct research on the mechanisms of mitochondrial dynamics, quality control, and mitochondrial DNA-mediated inflammation in alcohol-associated liver disease. The project aims to understand how chronically accumulated megamitochondria in the...
The federal Project Grant award F31AA031426, in the amount of $106,642.00, was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program. The award aims to elucidate the mechanisms by which alcohol exposure increases the expression of Wnt ligands, leading to canonical β-catenin activation and hepatic stellate cell transdifferentiation, to promote the early pathogenesis of liver fibrosis in alcohol-related...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program will fund research to identify the mechanisms responsible for the suppression of fibroblast growth factor 21 (FGF21) by the interferon regulatory factor 3 (IRF3) pathway in the context of alcohol consumption and alcohol-associated liver disease. The $537,587 award will support a 5-year research project focused on understanding how...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will fund a research project to study alcohol-associated liver disease (ALD) and its interaction with the rs738409 variant in the PNPLA3 gene using a human induced pluripotent stem cell (iPSC)-derived liver culture model. The $523,477 award, spanning from September 2024 to June 2029, will enable the Cleveland Clinic Lerner College of Medicine of...